SCHEMBL10136610

SCHEMBL10136610

Cc1cc(Cl)cc(C(=O)NC(C)C)c1NC(=O)c1cc(CN(C)S(=O)(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)nn1-c1ncccc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 3/20 0.33
GPBAR1 Q8TDU6 4/20 0.32
NAMPT P43490 1/20 0.31
ACLY P53396 1/20 0.31
LMNA P02545 2/20 0.31
PKM P14618 1/20 0.31
SLC12A2 P55011 1/20 0.31
SLC12A5 Q9H2X9 1/20 0.31
CYP3A4 P08684 1/20 0.31
UGCG Q16739 1/20 0.31
KMT2A Q03164 1/20 0.31
MMP1 P03956 1/20 0.31
MMP9 P14780 1/20 0.31
MMP13 P45452 1/20 0.31
ADAM17 P78536 1/20 0.31
TACR1 P25103 1/20 0.31
TP53 P04637 2/20 0.30
RXFP1 Q9HBX9 1/20 0.30
MAPT P10636 1/20 0.30
MALT1 Q9UDY8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10136233 0.91 TACR1 (0.33) DHODHCYP3A4UGCGTACR1
SCHEMBL10118322 0.88 ALDH1A1 (0.35) DHODHGPBAR1ACLYLMNATP53
SCHEMBL10136623 0.88 DHODH (0.35) DHODHCYP3A4UGCGKMT2ATACR1
SCHEMBL10136641 0.85 ALDH1A1 (0.34) DHODHCYP3A4UGCGTACR1MALT1
SCHEMBL10136626 0.84 POLB (0.37) DHODHLMNAKMT2ATP53MAPT
SCHEMBL10136612 0.84 ALDH1A1 (0.35) DHODHLMNACYP3A4UGCGTP53
SCHEMBL10136642 0.83 ALDH1A1 (0.35) DHODHCYP3A4UGCGTRPV1
SCHEMBL10118273 0.83 NPY5R (0.42) KMT2AMALT1TRPV1
SCHEMBL10136627 0.83 ALDH1A1 (0.39) DHODHLMNACYP3A4UGCGMALT1
SCHEMBL672741 0.82 PDE4B (0.36) DHODHKMT2AMAPTMALT1TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791139-B2 Anthranilic diamide derivatives BAYER CROPSCIENCE AG (DE) 2014-07-29 US disclosed
US-20120015980-A1 ANTHRANILIC DIAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015980-A1 ANTHRANILIC DIAMIDE DERIVATIVES DDT, QDPR, ANTXR2 DHODH 197/4885GPBAR1 1758/4885NAMPT 1704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.